<VariationArchive VariationID="812502" VariationName="NM_177924.5(ASAH1):c.256dup (p.Thr86fs)" VariationType="Duplication" Accession="VCV000812502" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-08" DateCreated="2020-02-16" MostRecentSubmission="2020-02-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="800739" VariationID="812502">
      <GeneList>
        <Gene Symbol="ASAH1" FullName="N-acylsphingosine amidohydrolase 1" GeneID="427" HGNC_ID="HGNC:735" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>8p22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="18055992" stop="18084961" display_start="18055992" display_stop="18084961" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="17913924" stop="17942506" display_start="17913924" display_stop="17942506" Strand="-" />
          </Location>
          <OMIM>613468</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_177924.5(ASAH1):c.256dup (p.Thr86fs)</Name>
      <CanonicalSPDI>NC_000008.11:18069838:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>8p22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="18069838" stop="18069839" display_start="18069838" display_stop="18069839" variantLength="1" positionVCF="18069838" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="17927347" stop="17927348" display_start="17927347" display_stop="17927348" variantLength="1" positionVCF="17927347" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>T21fs</ProteinChange>
      <ProteinChange>T86fs</ProteinChange>
      <ProteinChange>T102fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.17927348dup" Assembly="GRCh37">
            <Expression>NC_000008.10:g.17927348dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.18069839dup" Assembly="GRCh38">
            <Expression>NC_000008.11:g.18069839dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008985.2" sequenceAccession="NG_008985" sequenceVersion="2" change="g.20160dup">
            <Expression>NG_008985.2:g.20160dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363743.2" sequenceAccession="NM_001363743" sequenceVersion="2" change="c.61dup">
            <Expression>NM_001363743.2:c.61dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350672.1" sequenceAccession="NP_001350672" sequenceVersion="1" change="p.Thr21fs">
            <Expression>NP_001350672.1:p.Thr21fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004315.6" sequenceAccession="NM_004315" sequenceVersion="6" change="c.304dup">
            <Expression>NM_004315.6:c.304dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004306.3" sequenceAccession="NP_004306" sequenceVersion="3" change="p.Thr102fs">
            <Expression>NP_004306.3:p.Thr102fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_177924.5" sequenceAccession="NM_177924" sequenceVersion="5" change="c.256dup" MANESelect="true">
            <Expression>NM_177924.5:c.256dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_808592.2" sequenceAccession="NP_808592" sequenceVersion="2" change="p.Thr86fs">
            <Expression>NP_808592.2:p.Thr86fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127505.3" sequenceAccession="NM_001127505" sequenceVersion="3" change="c.285+1461dup">
            <Expression>NM_001127505.3:c.285+1461dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_177924.5" sequenceAccession="NM_177924" sequenceVersion="5" change="c.256_257insA" MANESelect="true">
            <Expression>NM_177924.5:c.256_257insA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1336696568" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_177924.5(ASAH1):c.256dup (p.Thr86fs) AND Farber lipogranulomatosis" Accession="RCV001003332" Version="2">
        <ClassifiedConditionList TraitSetID="43">
          <ClassifiedCondition DB="MedGen" ID="C0268255">Farber lipogranulomatosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-07-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-02-16" MostRecentSubmission="2020-02-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="DOI">10.3760/cma.j.issn.0578-1310.2017.01.011</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="43" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14121" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Farber's lipogranulomatosis</ElementValue>
                <XRef ID="79935000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Farber's disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Farber disease</ElementValue>
                <XRef ID="333" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Farber lipogranulomatosis</ElementValue>
                <XRef ID="MONDO:0009218" DB="MONDO" />
                <XRef ID="79935000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ceramidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acid ceramidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AC deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-Laurylsphingosine deacylase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FRBRL</ElementValue>
                <XRef Type="MIM" ID="228000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ASAH1-related disorders ranges from Farber disease (FD) to spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME). Classic FD is characterized by onset in the first weeks of life of painful, progressive deformity of the major joints; palpable subcutaneous nodules of joints and mechanical pressure points; and a hoarse cry resulting from granulomas of the larynx and epiglottis. Life expectancy is usually less than two years. In the other less common types of FD, onset, severity, and primary manifestations vary. SMA-PME is characterized by early-childhood-onset progressive lower motor neuron disease manifest typically between ages three and seven years as proximal lower-extremity weakness, followed by progressive myoclonic and atonic seizures, tremulousness/tremor, and sensorineural hearing loss. Myoclonic epilepsy typically begins in late childhood after the onset of weakness and can include jerking of the upper limbs, action myoclonus, myoclonic status, and eyelid myoclonus. Other findings include generalized tremor, and cognitive decline. The time from disease onset to death from respiratory complications is usually five to 15 years.</Attribute>
                <XRef ID="NBK488189" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6426" />
                <XRef ID="6426" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29595935</ID>
                <ID Source="BookShelf">NBK488189</ID>
              </Citation>
              <XRef ID="333" DB="Orphanet" />
              <XRef ID="C0268255" DB="MedGen" />
              <XRef ID="MONDO:0009218" DB="MONDO" />
              <XRef Type="MIM" ID="228000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2288713" SubmissionDate="2019-07-15" DateLastUpdated="2020-02-16" DateCreated="2020-02-16">
        <ClinVarSubmissionID localKey="Pt 74.1 NM_177924.5(ASAH1):c.256_257insA" localKeyIsSubmitted="1" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV001161417" DateUpdated="2020-02-16" DateCreated="2020-02-16" Type="SCV" Version="1" SubmitterName="Medical Affairs, Dicerna Pharmaceuticals" OrgID="507035" OrganizationCategory="other" OrgAbbreviation="MA" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="DOI">10.3760/cma.j.issn.0578-1310.2017.01.011</ID>
          </Citation>
          <Comment>Variant c.256_257InsA has been defined as pathogenic. The patient was diagnosed with severe Farber disease characteristic of Type 1 Farber disease as described by Gene Reviews (https://www.ncbi.nlm.nih.gov/books/NBK488189/). Histology of subcutaneous nodules showed the presence of foamy (lipid-filled) macrophages consistent with Farber disease. DNA sequencing revealed compound heterozygous ASAH1 variants, c.256_257insA and c.314T&gt;C. Variant c.256_257insA resulting in protein termination at position 86. Truncation of the protein renders the acid ceramidase enzyme inactive.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithSegregationObserved="1" NumFamiliesWithVariant="1">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <Description>ASAH1 sequence analysis described here: DOI: 10.3760/cma.j.issn.0578-1310.2017.01.011</Description>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">joint swelling</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">cognitive delay</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">painful joints</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">joint contractures</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">subcutaneous nodules</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">progressive hoarseness</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">subcutaneous nodules</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">hypomyelination</ElementValue>
                </Name>
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <Name>
                  <ElementValue Type="Preferred">cerebral atrophy</ElementValue>
                </Name>
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASAH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_177924.5:c.256_257insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="228000" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>The patient had two compound heterozygous variants, c.256_257insA and c.314T&gt;C. Parental genetic testing showed the c.256_257insA variant was inherited from the mother and the missense variant, c.314T&gt;C was inherited from the father.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB5958214</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2288713" TraitType="Finding" MappingType="Name" MappingValue="painful joints" MappingRef="Preferred">
        <MedGen CUI="None" Name="painful joints" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2288713" TraitType="Finding" MappingType="Name" MappingValue="progressive hoarseness" MappingRef="Preferred">
        <MedGen CUI="None" Name="progressive hoarseness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2288713" TraitType="Finding" MappingType="Name" MappingValue="hypomyelination" MappingRef="Preferred">
        <MedGen CUI="C4025616" Name="CNS hypomyelination" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2288713" TraitType="Disease" MappingType="XRef" MappingValue="228000" MappingRef="OMIM">
        <MedGen CUI="C0268255" Name="Farber lipogranulomatosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2288713" TraitType="Finding" MappingType="Name" MappingValue="cognitive delay" MappingRef="Preferred">
        <MedGen CUI="C0557874" Name="Global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2288713" TraitType="Finding" MappingType="Name" MappingValue="subcutaneous nodules" MappingRef="Preferred">
        <MedGen CUI="C0151811" Name="Subcutaneous nodule" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2288713" TraitType="Finding" MappingType="Name" MappingValue="cerebral atrophy" MappingRef="Preferred">
        <MedGen CUI="C0235946" Name="Cerebral atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2288713" TraitType="Finding" MappingType="Name" MappingValue="subcutaneous nodules" MappingRef="Preferred">
        <MedGen CUI="C0151811" Name="Subcutaneous nodule" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2288713" TraitType="Finding" MappingType="Name" MappingValue="joint contractures" MappingRef="Preferred">
        <MedGen CUI="C0009918" Name="Joint contracture" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2288713" TraitType="Finding" MappingType="Name" MappingValue="joint swelling" MappingRef="Preferred">
        <MedGen CUI="C0152031" Name="Joint swelling" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

